SenzaGen (Sweden) Market Value
| SENZA Stock | SEK 6.95 0.10 1.42% |
| Symbol | SenzaGen |
SenzaGen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SenzaGen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SenzaGen.
| 11/02/2024 |
| 12/02/2024 |
If you would invest 0.00 in SenzaGen on November 2, 2024 and sell it all today you would earn a total of 0.00 from holding SenzaGen AB or generate 0.0% return on investment in SenzaGen over 30 days. SenzaGen is related to or competes with Immunovia Publ, Sedana Medical, KABE Group, IAR Systems, Mekonomen, Embellence Group, and Norva24 Group. SenzaGen AB, together with its subsidiary, markets, sells, and performs in vitro genomic allergen rapid detection sensit... More
SenzaGen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SenzaGen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SenzaGen AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 11.26 | |||
| Value At Risk | (4.11) | |||
| Potential Upside | 4.08 |
SenzaGen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for SenzaGen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SenzaGen's standard deviation. In reality, there are many statistical measures that can use SenzaGen historical prices to predict the future SenzaGen's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | (0.31) |
SenzaGen AB Backtested Returns
SenzaGen AB owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0542, which indicates the firm had a -0.0542% return per unit of risk over the last 3 months. SenzaGen AB exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate SenzaGen's Variance of 5.62, coefficient of variation of (1,861), and Risk Adjusted Performance of (0.03) to confirm the risk estimate we provide. The entity has a beta of 0.45, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, SenzaGen's returns are expected to increase less than the market. However, during the bear market, the loss of holding SenzaGen is expected to be smaller as well. At this point, SenzaGen AB has a negative expected return of -0.13%. Please make sure to validate SenzaGen's skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if SenzaGen AB performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.26 |
Poor predictability
SenzaGen AB has poor predictability. Overlapping area represents the amount of predictability between SenzaGen time series from 2nd of November 2024 to 17th of November 2024 and 17th of November 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SenzaGen AB price movement. The serial correlation of 0.26 indicates that nearly 26.0% of current SenzaGen price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.26 | |
| Spearman Rank Test | -0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
SenzaGen AB lagged returns against current returns
Autocorrelation, which is SenzaGen stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting SenzaGen's stock expected returns. We can calculate the autocorrelation of SenzaGen returns to help us make a trade decision. For example, suppose you find that SenzaGen has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
SenzaGen regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If SenzaGen stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if SenzaGen stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in SenzaGen stock over time.
Current vs Lagged Prices |
| Timeline |
SenzaGen Lagged Returns
When evaluating SenzaGen's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of SenzaGen stock have on its future price. SenzaGen autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, SenzaGen autocorrelation shows the relationship between SenzaGen stock current value and its past values and can show if there is a momentum factor associated with investing in SenzaGen AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for SenzaGen Stock Analysis
When running SenzaGen's price analysis, check to measure SenzaGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenzaGen is operating at the current time. Most of SenzaGen's value examination focuses on studying past and present price action to predict the probability of SenzaGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenzaGen's price. Additionally, you may evaluate how the addition of SenzaGen to your portfolios can decrease your overall portfolio volatility.